The top news stories from France

Provided by AGP

The France Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The France Journal.

Press releases published on April 24, 2026

hiTechMODA Builds a Global Stage for the Next Big Names in Fashion
Theom Redefines AI & Data Security, Placing as a Leader Across Major Industry Analyst Evaluations
Parisian Engineer Wins 1941 Picasso as Charity Raffle Raises €12M for Alzheimer’s Research at Christie’s Drawing
French EDM Artist Apotiker Explores Music’s Role in Emotional Well-Being with Upcoming Releases
Awaji Island in Japan TV Anime Attack on Titan × Nijigen no Mori Collaboration Day Event 'Attack on Titan Mystery Quest'
Press Release: Sanofi successfully prices 2.3 billion of bond issue
Communiqué de presse : Sanofi place 2,3 milliard d’euros d’emprunts obligataires
Charlie Jbeily met en lumière la stratégie mondiale de XS.com en matière de talents dans une interview pour GameChangers
AI & Technology Virtual Investor Conference: Presentations Now Available for Online Viewing
Orientalischer Schmuck glänzt an der Seine: Chinas Perlenzentrum Zhuji wirbt in Paris für Stadt und Industrie
Bijoux orientaux à l’honneur sur les bords de Seine : la ville de Zhuji, centre perlier chinois, promeut son patrimoine et son industrie à Paris
Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses
Communiqué de presse : Cenrifki de Sanofi (tolebrutinib) recommandé par le Comité des médicaments à usage humain (CMUH) pour être approuvé par l’UE pour le traitement de la sclérose en plaques secondairement progressive sans poussées
EXEL Industries: Q2 2025–2026 revenue -12.1%
EXEL Industries : Chiffre d’affaires 2e trimestre 2025–2026 -12,1%

Share us

on your social networks:

Sign up for:

The France Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.